Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Mongolian population in China
- PMID: 20845310
- DOI: 10.4238/vol9-3gmr938
Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Mongolian population in China
Abstract
We examined the distribution of major allelic variants of CYP2C9 and CYP2C19 in the Mongolian population of China and compared it with that of other populations. The polymorphisms of CYP2C9 (including the CYP2C9*1, CYP2C9*2 and CYP2C9*3 alleles) and CYP2C19 (including the CYP2C19*1, CYP2C19*2 and CYP2C19*3 alleles) were analyzed in 280 healthy unrelated Chinese Mongolian subjects, using a PCR-RFLP assay. The frequencies of CYP2C9*1, *2 and *3 alleles were 0.97, 0.00 and 0.03, respectively. The frequencies of CYP2C19*1, *2 and *3 alleles were 0.72, 0.24 and 0.04, respectively. We did not find any differences in the allelic distribution of these two genes between age groups. However, the genotype frequency of CYP2C9 *1/*3 was significantly higher in males than in females. Compared with other populations, we found that the allele frequencies of the CYP2C9*2 and CYP2C9*3 allelic variants in this Mongolian population of China were similar to those reported for other Asian populations, with significant differences compared to Caucasians and African-Americans.
Similar articles
-
Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Iranian population.Clin Exp Pharmacol Physiol. 2007 Jan-Feb;34(1-2):102-5. doi: 10.1111/j.1440-1681.2007.04538.x. Clin Exp Pharmacol Physiol. 2007. PMID: 17201743
-
Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.Pharmacol Res. 2004 Aug;50(2):195-200. doi: 10.1016/j.phrs.2004.01.004. Pharmacol Res. 2004. PMID: 15177309
-
Genetic polymorphism of CYP2C9 and CYP2C19 in a Bolivian population: an investigative and comparative study.Eur J Clin Pharmacol. 2005 May;61(3):179-84. doi: 10.1007/s00228-004-0890-5. Epub 2005 Mar 18. Eur J Clin Pharmacol. 2005. PMID: 15776277
-
Impact of genetic polymorphisms in CYP2C9 and CYP2C19 on the pharmacokinetics of clinically used drugs.Drug Metab Pharmacokinet. 2013;28(1):28-37. doi: 10.2133/dmpk.dmpk-12-rv-085. Epub 2012 Nov 20. Drug Metab Pharmacokinet. 2013. PMID: 23165865 Review.
-
The pharmacogenetics of CYP2C9 and CYP2C19: ethnic variation and clinical significance.Curr Clin Pharmacol. 2007 Jan;2(1):93-109. doi: 10.2174/157488407779422302. Curr Clin Pharmacol. 2007. PMID: 18690857 Review.
Cited by
-
Inhibition of Human Cytochrome P450 Enzymes by Allergen Removed Rhus verniciflua Stoke Standardized Extract and Constituents.Evid Based Complement Alternat Med. 2014;2014:150351. doi: 10.1155/2014/150351. Epub 2014 Jun 30. Evid Based Complement Alternat Med. 2014. PMID: 25061471 Free PMC article.
-
Inconsistency in race and ethnic classification in pharmacogenetics studies and its potential clinical implications.Pharmgenomics Pers Med. 2019 Jul 2;12:107-123. doi: 10.2147/PGPM.S207449. eCollection 2019. Pharmgenomics Pers Med. 2019. PMID: 31308725 Free PMC article.
-
Genetic Polymorphism of CYP2C9 Among Sistani Ethnic Group in Gorgan.Indian J Clin Biochem. 2018 Apr;33(2):208-213. doi: 10.1007/s12291-017-0660-7. Epub 2017 May 26. Indian J Clin Biochem. 2018. PMID: 29651213 Free PMC article.
-
Effects of genetic polymorphism of drug-metabolizing enzymes on the plasma concentrations of antiepileptic drugs in Chinese population.Bioengineered. 2022 Mar;13(3):7709-7745. doi: 10.1080/21655979.2022.2036916. Bioengineered. 2022. PMID: 35290166 Free PMC article. Review.
-
Percentage fractions of urinary di(2-ethylhexyl) phthalate metabolites: Association with obesity and insulin resistance in Korean girls.PLoS One. 2018 Nov 27;13(11):e0208081. doi: 10.1371/journal.pone.0208081. eCollection 2018. PLoS One. 2018. PMID: 30481198 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources